Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients

ClinicalTrials.gov ID: NCT00001089

Public ClinicalTrials.gov record NCT00001089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 9:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Human Immunodeficiency Virus (HIV) and Cytomegalovirus (CMV) Viral Burden and Development of CMV End-Organ Disease: A Prospective Study in HIV-Infected Individuals.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To define relationships between 1) HIV load and risk of CMV disease, 2) CMV load and the risk of developing CMV disease, and 3) CMV load and HIV load. To establish threshold CMV and HIV load values in peripheral blood fractions that are associated with development of CMV end-organ disease. To define the natural history of CMV diseases in the context of highly active antiretroviral therapy (HAART). Establishment of threshold CMV and HIV load values associated with CMV disease would facilitate identification of HIV-infected individuals truly at risk for CMV disease in whom targeted prophylactic interventions to prevent CMV disease would be indicated. These studies would also further the understanding of the natural history of CMV disease within the context of AIDS. Natural history studies conducted prior to the advent of highly active antiretroviral therapy (HAART; i.e., 3-drug regimens that include HIV reverse transcriptase and protease inhibitors) have demonstrated that the risk for developing CMV disease increases with progression of HIV disease and with declining CD4 counts. Presently the need exists to define the natural history of CMV disease in patients with AIDS within the context of HAART.

Study identification

NCT ID
NCT00001089
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
400 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
36
U.S. states
20
U.S. cities
26
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294
Univ of Southern California / LA County USC Med Ctr Los Angeles California 900331079
Los Angeles County - USC Med Ctr Los Angeles California 90033
UCLA CARE Ctr Los Angeles California 90095
Stanford at Kaiser / Kaiser Permanente Med Ctr San Francisco California 94115
San Mateo AIDS Program / Stanford Univ Stanford California 943055107
Harbor UCLA Med Ctr Torrance California 90502
Children's Hosp of Denver Denver Colorado 802181088
Children's Hosp of Washington DC Washington D.C. District of Columbia 200102916
Univ of Miami School of Medicine Miami Florida 331361013
Emory Univ Hosp / Pediatrics Atlanta Georgia 30306
Queens Med Ctr Honolulu Hawaii 96816
Louis A Weiss Memorial Hosp Chicago Illinois 60640
Indiana Univ Hosp Indianapolis Indiana 462025250
Division of Inf Diseases/ Indiana Univ Hosp Indianapolis Indiana 46202
Methodist Hosp of Indiana / Life Care Clinic Indianapolis Indiana 46202
Charity Hosp / Tulane Univ Med School New Orleans Louisiana 70112
Johns Hopkins Hosp Baltimore Maryland 21287
Harvard (Massachusetts Gen Hosp) Boston Massachusetts 02114
Boston Med Ctr Boston Massachusetts 02118
Beth Israel Deaconess - West Campus Boston Massachusetts 02215
Beth Israel Deaconess Med Ctr Boston Massachusetts 02215
Hennepin County Med Clinic Minneapolis Minnesota 55415
St Paul Ramsey Med Ctr Saint Paul Minnesota 55101
St Louis Regional Hosp / St Louis Regional Med Ctr St Louis Missouri 63112
Bellevue Hosp / New York Univ Med Ctr New York New York 10016
Mem Sloan - Kettering Cancer Ctr New York New York 10021
St Vincent's Hosp / Mem Sloan-Kettering Cancer Ctr New York New York 10021
Community Health Network Inc Rochester New York 14642
Univ of Rochester Medical Center Rochester New York 14642
Montefiore Med Ctr Adolescent AIDS Program The Bronx New York 10467
Univ of North Carolina Chapel Hill North Carolina 275997215
Univ of Cincinnati Cincinnati Ohio 452670405
Univ of Pennsylvania at Philadelphia Philadelphia Pennsylvania 19104
Julio Arroyo West Columbia South Carolina 29169
Univ of Tennessee / E Tennessee Comprehensive Hemophilia Ctr Knoxville Tennessee 37920

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001089 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →